Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Proteins & Antibodies | eBooks & Best Practices

Oxford Global's R&D Key 40 Stories 2022

24 October 2022
Download a copy of the R&D Key 40 Stories 2022 eBook today.
Read the full document

We are pleased to share with you selected highlights from Oxford Global’s content portfolios that we have been building over the past few years. In this eBook, a culmination of our efforts, we are delighted to present a variety of the most successful and widely read pieces we have released on our Biologics portal, providing you with invaluable insights into innovative biotherapeutic modalities & developments in biopharmaceutical manufacturing, through to the impact of AI/ML in biologics drug discovery.

Sample (click to enlarge)

To read the eBook in full, please click below to launch our immersive eBook reader

 

Read the full document

Related Resources

Rapid Analytical Approach for Biologics Characterization Using Mass Photometry

On-demand webinar featuring Dr Racha Majed, Technical Sales Specialist, Refeyn
Read More

The Current Landscape of ADC Approvals and Market Trends: Q&A With Mahendra Deonarain, CEO of Antikor Biopharma

While a recent spike in ADC approvals may not last forever, Antikor Biopharma’s Mahendra Deonarain asserts that antibody-drug conjugates are here to stay.
Read More

Related Online Activities

Join the conversation with our upcoming Monthly Science Exchanges and Webinars:
08/04/24
Harnessing The Immune System With NK Cell Engagers
15/05/24
Building a Strong ADC Patent Portfolio – From Prosecution and Litigation Perspectives